Online Program

Return to main conference page

All Times EDT

Friday, September 25
Fri, Sep 25, 3:30 PM - 4:45 PM
Virtual
Challenges and Recommendations in Using Biomarker/Surrogate Endpoints for the Accelerated Approval

Peter Mesenbrink's Discussion (302312)

View Video

*Peter Mesenbrink, Novartis